Key Takeaways BAX's Q4 revenues are likely to rise 1.5% year over year, while earnings per share are projected to fall 8.6%.BAX continues to face pressure from infusion pump shipment holds and IV fluid conservation in U.S. hospitals.BAX sees partial offsets from strong Advanced Surgery demand, solid HST orders and lower interest expense.Baxter International Inc. (BAX) is scheduled to release fourth-quarter 2025 results on Feb. 12, before the opening bell. In the last reported quarter, the company’s earnings ...